Oregon Public Employees Retirement Fund Arcus Biosciences, Inc. Transaction History
Oregon Public Employees Retirement Fund
- $5.14 Billion
- Q4 2024
A detailed history of Oregon Public Employees Retirement Fund transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Oregon Public Employees Retirement Fund holds 12,681 shares of RCUS stock, worth $113,368. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,681
Previous 12,681
-0.0%
Holding current value
$113,368
Previous $193,000
2.59%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RCUS
# of Institutions
201Shares Held
51.2MCall Options Held
288KPut Options Held
138K-
Black Rock Inc. New York, NY9.76MShares$87.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.39MShares$48.2 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.52MShares$31.5 Million0.39% of portfolio
-
State Street Corp Boston, MA2.99MShares$26.8 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2MShares$17.8 Million0.07% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $645M
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...